Sign up to save your podcasts
Or
Share Nina van Schaick - Fundraising Founder of Peripear
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Nina van Schaick - Fundraising Founder of Peripear
Episode 11 - Fundraising Founder: Nina van Schaick- Peripear
In this episode of AtVenture Dealflow, host Laurie Lancee speaks with Nina van Schaick - co-Founder and COO of Peripear
PeriPear is a femtech medtech startup focused on preventing perineal trauma during vaginal birth.
Despite strong clinical evidence showing that birth injuries can be reduced by up to 50%, prevention has failed to scale in daily clinical practice.
PeriPear addresses this gap with a non-invasive medical device designed to fit existing clinical workflows, without requiring behaviour change from women or clinicians.
In this episode, Nina shares how her background as a midwife led her to build a scalable, evidence-based solution for one of the most under-addressed issues in women’s health, and what it takes to build a capital-efficient femtech company in a regulated healthcare market.
Key Metrics: PeriPear
- Sector: FemTech / MedTech / Women’s Health
- Business Model: B2B medical device (hospitals & birth centres)
- Founded: 2020 (UK-based, global focus)
- Team: Clinically led founding team with deep midwifery and healthcare expertise
- Traction: Strong clinical validation; growing adoption in birth care settings
- Round: Pre-seed
- Use of funds: Clinical validation, manufacturing, regulatory progress and market entry
- Market: ~90% of vaginal births involve perineal trauma, yet prevention remains inconsistent
- Impact: Reducing birth injuries, long-term pelvic floor damage and associated healthcare and workforce costs
🎧 Listen to the full episode of AtVenture DealFlow to learn why prevention in birth care has lagged behind for decades, how PeriPear is building real clinical traction across continents, and what investors should understand about femtech and regulated health innovation.
More: www.atventureplatform.com
See you at the next great deal.
View all episodes
By AtVenture PlatformEpisode 11 - Fundraising Founder: Nina van Schaick- Peripear
In this episode of AtVenture Dealflow, host Laurie Lancee speaks with Nina van Schaick - co-Founder and COO of Peripear
PeriPear is a femtech medtech startup focused on preventing perineal trauma during vaginal birth.
Despite strong clinical evidence showing that birth injuries can be reduced by up to 50%, prevention has failed to scale in daily clinical practice.
PeriPear addresses this gap with a non-invasive medical device designed to fit existing clinical workflows, without requiring behaviour change from women or clinicians.
In this episode, Nina shares how her background as a midwife led her to build a scalable, evidence-based solution for one of the most under-addressed issues in women’s health, and what it takes to build a capital-efficient femtech company in a regulated healthcare market.
Key Metrics: PeriPear
- Sector: FemTech / MedTech / Women’s Health
- Business Model: B2B medical device (hospitals & birth centres)
- Founded: 2020 (UK-based, global focus)
- Team: Clinically led founding team with deep midwifery and healthcare expertise
- Traction: Strong clinical validation; growing adoption in birth care settings
- Round: Pre-seed
- Use of funds: Clinical validation, manufacturing, regulatory progress and market entry
- Market: ~90% of vaginal births involve perineal trauma, yet prevention remains inconsistent
- Impact: Reducing birth injuries, long-term pelvic floor damage and associated healthcare and workforce costs
🎧 Listen to the full episode of AtVenture DealFlow to learn why prevention in birth care has lagged behind for decades, how PeriPear is building real clinical traction across continents, and what investors should understand about femtech and regulated health innovation.
More: www.atventureplatform.com
See you at the next great deal.